SCHEMBL3945989

SCHEMBL3945989

Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-n5ccnc5)n4)c3)cc(C(F)(F)F)c2)cn1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 11/20 0.73
▸ BCR P11274 6/20 0.73
▸ ADORA3 P0DMS8 2/20 0.73
▸ KDR P35968 2/20 0.73
▸ NR1I2 O75469 1/20 0.73
▸ PTGS1 P23219 1/20 0.73
▸ CHRNA4 P43681 1/20 0.73
▸ PDE3A Q14432 1/20 0.73
▸ KIT P10721 5/20 0.73
▸ PDGFRB P09619 4/20 0.73
▸ LDLR P01130 3/20 0.73
▸ PCSK9 Q8NBP7 3/20 0.73
▸ LCK P06239 4/20 0.72
▸ LYN P07948 4/20 0.72
▸ PDGFRA P16234 3/20 0.72
▸ FLT3 P36888 3/20 0.72
▸ DDR2 Q16832 3/20 0.72
▸ HCK P08631 3/20 0.72
▸ EPHB2 P29323 2/20 0.72
▸ RAF1 P04049 2/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15703764 0.94 ABL1 (0.79) ABL1BCRADORA3KDRNR1I2
SCHEMBL3952869 0.92 ABL1 (0.63) ABL1BCRADORA3KDRNR1I2
SCHEMBL3947972 0.89 ABL1 (0.72) ABL1BCRADORA3KDRNR1I2
SCHEMBL4176681 0.88 CSF1R (0.60) ABL1BCRADORA3KDRNR1I2
SCHEMBL3952991 0.88 ABL1 (0.68) ABL1BCRADORA3KDRNR1I2
SCHEMBL20502614 0.88 ABL1 (0.81) ABL1BCRADORA3KDRNR1I2
SCHEMBL3952436 0.87 NR2E1 (0.69) ABL1BCRADORA3KDRNR1I2
SCHEMBL20502607 0.86 KIT (0.89) ABL1BCRADORA3KDRNR1I2
SCHEMBL22169883 0.86 ABL1 (0.68) ABL1BCRADORA3KDRNR1I2
SCHEMBL20502615 0.86 ABL1 (0.76) ABL1BCRADORA3KDRNR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1922309-B1 N-PHENYL-2-PYRIMIDINE-AMINE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF IL YANG PHARM CO LTD (KR) 2014-05-21 — — EP disclosed
US-7501424-B2 N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof IL-YANG PHARM. CO., LTD. (KR) 2009-03-10 — — US disclosed
US-20080096899-A1 N-Phenyl-2-Pyrimidine-Amine Derivatives and Process for the Preparation Thereof IL-YANG PHARM. CO., LTD. (KR) 2008-04-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096899-A1 N-Phenyl-2-Pyrimidine-Amine Derivatives and Process for the Preparation Thereof ITPA, TYMP, THPO ABL1 451/4885BCR 990/4885ADORA3 222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback